TVTX
Travere Therapeutics Inc
57.70$
+1.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +254.2% | +33.7% | +16.0% | +6.0% | +6.8% | +13.1% | -33.5% | -17.0% | +32.7% | +60.5% | +110.5% | |
| – | +282.7% | +108.4% | -20.8% | +53.3% | -5.3% | +17.0% | -37.7% | +15.8% | +159.0% | -32.4% | +33.5% | |
| – | +253.6% | +32.1% | +17.3% | +4.9% | +7.2% | +13.0% | -33.4% | -17.9% | +27.4% | +68.5% | +113.1% | |
| – | +5.5% | +40.5% | +10.3% | +58.3% | +13.9% | -6.5% | +52.7% | +13.0% | +7.8% | +15.4% | -27.1% | |
| – | +33.4% | +23.2% | +6.1% | -0.3% | +24.4% | +5.3% | -7.0% | +56.4% | +34.4% | -0.5% | +27.7% | |
| – | +21.0% | +29.9% | +7.9% | +24.9% | +18.7% | +36.5% | -11.1% | +29.7% | +22.8% | +5.2% | -1.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -64.6% | -75.7% | -6.6% | +121.8% | +91.9% | +1.2% | +3.3% | -44.0% | +2.9% | -1.3% | -3.9% | |
| – | – | -154.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -40.7% | -102.6% | – | – | -23.5% | -28.8% | -46.2% | +723.3% | |
| – | – | -140.9% | – | – | – | – | – | – | – | – | – | |
| – | – | -130.0% | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.